@Wise_One you should be a bit less hasty to accuse others of being incompetent. If you go to the last 4C you will see that the company had $6,968,000 in cash as of the 30th September 2018 (5.5 on page 3) and that they intended to spend $1,965,000 this quarter (9.8 on page 4). Since we are near the end of the quarter the company has aproximatly $5 million left in the bank.
If they keep spending at this rate (spending is actually likely to rise as they get into the clinical phase), then by the end of June they will only have around a million dollars left. Then what?
An opinion on the commercial prospects of RHY, page-5
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.41M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5969 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 5500 | 1 |
View Market Depth
| Last trade - 16.16pm 18/11/2024 (20 minute delay) ? |
| RHY (ASX) Chart |
Day chart unavailable
